Patients across the UK will benefit from innovative and life-changing treatments following a cut in rebate costs for pharmaceutical companies.
A pharmaceuticals trade deal with the US has been hailed by the Government as a ‘landmark’ agreement and good for economic growth and investment but the long-term implications for the NHS may not b...
Ahead of the announcement of an expected pharma deal with the US in the Autumn Budget, chief policy analyst at the Nuffield Trust, Sally Gainsbury, warns there is a real danger the NHS budget is no...
The price the NHS pays for drugs looks set to rise as Prime Minister Sir Keir Starmer is set to agree to US President Donald Trump’s demands to pay pharmaceutical companies more money, in a bid to ...
The price the NHS pays for medicines will need to rise to stop pharmaceutical investment leaving the UK, science minister Patrick Vallance has said.
Health and social care secretary Wes Streeting has vowed not to allow pharmaceutical companies to 'rip off' British taxpayers after failed talks over drug pricing.
Sandwell, West MidlandsBand D, SCP 9 -17 (£27,254- £31,022 per annum), pro rata
Sandwell, West MidlandsBand G SCP 32-37 (£42,839 - £48,226 per annum)
Wakefield, West Yorkshire£16,030.50 - £17,217.00, Grade 7, 18.5 hours, Permanent
Sandwell, West MidlandsBand D, SCP 9 -17 (£27,254- £31,022 per annum), pro rata
Sandwell, West MidlandsBand G SCP 32-37 (£42,839 - £48,226 per annum)
Wakefield, West Yorkshire£16,030.50 - £17,217.00, Grade 7, 18.5 hours, Permanent